Source: Fox Chase Cancer (FCC) Center
FCCC has identified several drug candidates that have the ability to de-catalyze
the activity of the bio-catalysts critical for cancer and other diseases while seeking
to avoid major side effects.
FCC says that the results of this study will appear in the November issue of
Nature Biotechnology.......Read more
FCCC has identified several drug candidates that have the ability to de-catalyze
the activity of the bio-catalysts critical for cancer and other diseases while seeking
to avoid major side effects.
FCC says that the results of this study will appear in the November issue of
Nature Biotechnology.......Read more
